Media 28 May 2019 Bell Potter launches placement for Orthocell Orthcell's planned equity raise has been featured in AFR's Street Talk. Orthocell
Media 14 May 2019 Orthocell shares spike 350% following interim results of Celgro nerve regeneration study Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients… Orthocell
Video 08 May 2019 Orthocell unveils first clinical trial results for nerve regeneration platform CelGro Early results from Orthocell's nerve regeneration study have been featured in Small Caps. Read the article HERE. Orthocell
